title: What are the current guidelines and rationale for vancomycin monitoring?
abstract: Vancomycin is an antibiotic that can be challenging from a therapeutic and monitoring standpoint. Guidelines suggest certain situations where monitoring is encouraged; this article outlines those situations.
authors.affiliation: Lawrence Carey is a clinical associate professor in the Temple University School of Pharmacy and a lecturer in pharmacotherapeutics and former program director of the PA program at Philadelphia University in Philadelphia, Pa. The author has disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Lawrence
authors.initials: L
authors.lastname: Carey
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016903:Drug Monitoring / Q000592:standards*; D006801:Humans; D017410:Practice Guidelines as Topic; D014640:Vancomycin / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin